[Market Focus] Medicox Plunges Over 16% on "15-to-1 Free Capital Reduction" News

Medicox shares plunged sharply in early trading on June 5 following news of a "15-to-1 free capital reduction."

As of 9:15 a.m. on this day, Medicox was trading at 180 won, down 35 won (16.28%) from the previous trading day.

After the market closed the previous day, Medicox announced that it had decided on a 15-to-1 free capital reduction, merging 15 common shares into one share of the same par value. The company cited its intention to improve its financial structure by offsetting accumulated deficits as the reason for this decision.

A free capital reduction refers to reducing capital by consolidating shares or reducing the par value of shares without compensating shareholders. The capital surplus generated from the reduction can be used to offset accumulated deficits, helping the company avoid capital impairment. In theory, the total investment value of shareholders' holdings remains unchanged, but such measures are often interpreted as a sign of poor financial health, prompting many investors to sell their shares.

As a result of this capital reduction, Medicox's capital will decrease from approximately 41.4 billion won to about 2.8 billion won. The record date for the capital reduction is July 4, and the new shares are scheduled to be listed on August 1.

This content was produced with the assistance of AI translation services.